Development of an in vitro pseudo-neutralization assay to assess the efficacy of anti-SARS-CoV-2 antibodies
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202112GSM
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$13,825Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
Université de MontréalResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
Gender
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable